Sotera Health Company revised earnings guidance for the full year 2023. The company expects Net revenues in the range of $1.035 to $1.055 billion, from previous guidance of $1.055 billion to $1.090 billion, representing growth of approximately 3% to 5%, compared to the prior year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.33 USD | +1.03% | +3.85% | -32.76% |
05-02 | Sotera Health Shares Fall After Q1 Results, Outlook Reaffirmed | MT |
05-02 | Transcript : Sotera Health Company, Q1 2024 Earnings Call, May 02, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.76% | 3.17B | |
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- SHC Stock
- News Sotera Health Company
- Sotera Health Company Revises Earnings Guidance for the Full Year 2023